Clinical Trial

A Study to Assess the Safety, Tolerability and Efficacy of ION775

Name: A Study to Assess the Safety, Tolerability and Efficacy of ION775 — clinical trial record (NCT07604974)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).

Protocol Amendment History 2 changes

notable Trial sites expanded: 8 -> 16 locations 2026-06-19

notable Trial sites expanded: 3 -> 8 locations 2026-06-02

Trial Details

NCT Number	NCT07604974
Lead Sponsor	Ionis Pharmaceuticals, Inc.
Conditions	Hypertriglyceridemia, Severe Hypertriglyceridemia
Enrollment	72 participants
Start Date	2026-05-12
Primary Completion	2027-09 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-06-18